Naomi Fineberg

Dr. Naomi Fineberg


Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 November 2009 in Neuropsychopharmacology
Verified
Journal Article
Closed access
NFNaomi Fineberg
Naomi Fineberg
MPMarc N Potenza
Marc N Potenza
SCSamuel R Chamberlain
Samuel R Chamberlain
HBHeather A Berlin
Heather A Berlin
LMLara Menzies
Lara Menzies
EHEric Hollander
Eric Hollander

16 August 2022 in Comprehensive Psychiatry
Verified
Journal Article
Open access
NFNaomi Fineberg
Naomi Fineberg
JMJosé M. Menchón
José M. Menchón
NHNatalie Hall
Natalie Hall
BDBernardo Dell'Osso
Bernardo Dell'Osso
MBMatthias Brand
Matthias Brand
JZJoseph Zohar
Joseph Zohar
Global concern about problematic usage of the internet (PUI), and its public health and societal costs, continues to grow, sharpened in focus under the privations of the COVID-19 pandemic. This narrative review reports the expert opinions of members of the largest international network of researchers on PUI in the framework of the European Cooperation in Science and Technology (COST) Action (CA 16207), on the scientific progress made and the critical knowledge gaps remaining to be filled as the term of the Action reaches its conclusion. A key advance has been achieving consensus on the clinical definition of various forms of PUI. Based on the overarching public health principles of protecting individuals and the public from harm and promoting the highest attainable standard of health, the World Health Organisation has introduced several new structured diagnoses into the ICD-11, including gambling disorder, gaming disorder, compulsive sexual behaviour disorder, and other unspecified or specified disorders due to addictive behaviours, alongside naming online activity as a diagnostic specifier. These definitions provide for the first time a sound platform for developing systematic networked research into various forms of PUI at global scale. Progress has also been made in areas such as refining and simplifying some of the available assessment instruments, clarifying the underpinning brain-based and social determinants, and building more empirically based etiological models, as a basis for therapeutic intervention, alongside public engagement initiatives. However, important gaps in our knowledge remain to be tackled. Principal among these include a better understanding of the course and evolution of the PUI-related problems, across different age groups, genders and other specific vulnerable groups, reliable methods for early identification of individuals at risk (before PUI becomes disordered), efficacious preventative and therapeutic interventions and ethical health and social policy changes that adequately safeguard human digital rights. The paper concludes with recommendations for achievable research goals, based on longitudinal analysis of a large multinational cohort co-designed with public stakeholders.

27 January 2020 in BMC Medicine
Verified
Journal Article
Open access
PDF file
DSDan J. Stein
Dan J. Stein
PSPeter Szatmari
Peter Szatmari
WGWolfgang Gaebel
Wolfgang Gaebel
MBMichael Berk
Michael Berk
Eduard VietaEduard Vieta
Eduard Vieta
GRGeoffrey M. Reed
Geoffrey M. Reed
An update of the chapter on Mental, Behavioral and Neurodevelopmental Disorders in the International Classification of Diseases and Related Health Problems (ICD) is of great interest around the world. The recent approval of the 11th Revision of the ICD (ICD-11) by the World Health Organization (WHO) raises broad questions about the status of nosology of mental disorders as a whole as well as more focused questions regarding changes to the diagnostic guidelines for specific conditions and the implications of these changes for practice and research. This Forum brings together a broad range of experts to reflect on key changes and controversies in the ICD-11 classification of mental disorders. Taken together, there is consensus that the WHO’s focus on global applicability and clinical utility in developing the diagnostic guidelines for this chapter will maximize the likelihood that it will be adopted by mental health professionals and administrators. This focus is also expected to enhance the application of the guidelines in non-specialist settings and their usefulness for scaling up evidence-based interventions. The new mental disorders classification in ICD-11 and its accompanying diagnostic guidelines therefore represent an important, albeit iterative, advance for the field.

1 January 1999 in International Journal of Neuropsychopharmacology
Verified
Journal Article
Open access
PDF file
NFNaomi Fineberg
Naomi Fineberg
TGTim M. Gale
Tim M. Gale
Obsessive–compulsive disorder is a prevalent and disabling lifespan disorder. Clomipramine and the SSRIs have been found to be effective across the r

28 July 2022 in The World Journal of Biological Psychiatry
Verified
Journal Article
Closed access
BBBorwin Bandelow
Borwin Bandelow
CAChrister Allgulander
Christer Allgulander
DBDavid S. Baldwin
David S. Baldwin
DCDaniel Lucas da Conceição Costa
Daniel Lucas da Conceição Costa
DDDamiaan Denys
Damiaan Denys
JZJoseph Zohar
Joseph Zohar
This is the third version of the guideline of the World Federation of Societies of Biological Psychiatry (WFSBP) Task Force for the Pharmacological Treatment of Anxiety, Obsessive–Compulsive and Po...

1 April 2019 in European Neuropsychopharmacology
Verified
Journal Article
Open access
NFNaomi Fineberg
Naomi Fineberg
BDBernardo Dell'Osso
Bernardo Dell'Osso
UAUmberto Albert
Umberto Albert
GMGiuseppe Maina
Giuseppe Maina
DGDaniel Geller
Daniel Geller
JZJoseph Zohar
Joseph Zohar
Obsessive-compulsive disorder (OCD) is common, emerges early in life and tends to run a chronic, impairing course. Despite the availability of effective treatments, the duration of untreated illness (DUI) is high (up to around 10 years in adults) and is associated with considerable suffering for the individual and their families. This consensus statement represents the views of an international group of expert clinicians, including child and adult psychiatrists, psychologists and neuroscientists, working both in high and low and middle income countries, as well as those with the experience of living with OCD. The statement draws together evidence from epidemiological, clinical, health economic and brain imaging studies documenting the negative impact associated with treatment delay on clinical outcomes, and supporting the importance of early clinical intervention. It draws parallels between OCD and other disorders for which early intervention is recognized as beneficial, such as psychotic disorders and impulsive-compulsive disorders associated with problematic usage of the Internet, for which early intervention may prevent the development of later addictive disorders. It also generates new heuristics for exploring the brain-based mechanisms moderating the 'toxic' effect of an extended DUI in OCD. The statement concludes that there is a global unmet need for early intervention services for OC related disorders to reduce the unnecessary suffering and costly disability associated with under-treatment. New clinical staging models for OCD that may be used to facilitate primary, secondary and tertiary prevention within this context are proposed.